Innovations Center, Truth Initiative, Washington, DC.
Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
JAMA. 2024 Sep 3;332(9):713-721. doi: 10.1001/jama.2024.11057.
E-cigarettes are the most commonly used tobacco product among adolescents. Despite known harms of nicotine exposure among teens, there are no empirically tested vaping cessation interventions.
To compare the effectiveness of a text message program for nicotine vaping cessation among adolescents with assessment-only control.
DESIGN, SETTING, AND PARTICIPANTS: A parallel, 2-group, double-blind, individually randomized clinical trial with follow-ups at 1 and 7 months after randomization was conducted from October 1, 2021, to October 18, 2023. Participants were recruited via social media ads; the intervention was delivered via text message; and assessments were completed online or by telephone. Eligible individuals were US residents aged 13 to 17 years who reported past 30-day e-cigarette use, were interested in quitting within 30 days, and owned a mobile phone with an active text message plan. To optimize study retention, all participants received monthly assessments via text message about e-cigarette use.
Assessment-only controls (n = 744) received only study retention text messages. Intervention participants (n = 759) also received an automated, interactive text message program for vaping cessation that delivers cognitive and behavioral coping skills training and social support.
The primary outcome was self-reported 30-day point-prevalence abstinence from vaping at 7 months analyzed as intention-to-treat, with missingness coded as vaping.
Among n = 1503 adolescents randomized, average age was 16.4 (SD, 0.8) years. The sample was 50.6% female, 42.1% male, and 7.4% nonbinary/other; 10.2% Black/African American, 62.6% White, 18.5% multiracial, and 8.7% another race; 16.2% Hispanic; 42.5% sexual minority; and 76.2% vaped within 30 minutes of waking. The 7-month follow-up rate was 70.8%. Point-prevalence abstinence rates were 37.8% (95% CI, 34.4%-41.3%) among intervention participants and 28.0% (95% CI, 24.9%-31.3%) among control participants (relative risk, 1.35 [95% CI, 1.17-1.57]; P < .001). No baseline variables moderated the treatment-outcome relationship. There was no evidence that adolescents who quit vaping transitioned to combustible tobacco products.
A tailored, interactive text message intervention increased self-reported vaping cessation rates among adolescents recruited via social media channels.
ClinicalTrials.gov Identifier: NCT04919590.
电子烟是青少年最常使用的烟草产品。尽管青少年接触尼古丁的已知危害,但目前还没有经过实证检验的电子烟戒除干预措施。
比较短信程序对青少年尼古丁电子烟戒除的有效性,与仅评估对照组相比。
设计、地点和参与者:这是一项平行、2 组、双盲、个体随机临床试验,从 2021 年 10 月 1 日至 2023 年 10 月 18 日进行了 1 个月和 7 个月的随访。参与者通过社交媒体广告招募;干预措施通过短信发送;评估通过在线或电话完成。合格的参与者是美国 13 至 17 岁的居民,他们报告过去 30 天使用电子烟,有在 30 天内戒烟的意愿,并且拥有带有有效短信计划的移动电话。为了优化研究保留率,所有参与者每月都会通过短信收到有关电子烟使用情况的评估。
仅评估对照组(n = 744)仅接受研究保留短信。干预组参与者(n = 759)还接受了一个自动的、互动的电子烟戒除短信程序,提供认知和行为应对技能培训和社会支持。
主要结果是在 7 个月时自我报告的 30 天点前电子烟戒除率,分析为意向治疗,缺失值编码为电子烟使用。
在随机分配的 n = 1503 名青少年中,平均年龄为 16.4(标准差,0.8)岁。该样本中 50.6%为女性,42.1%为男性,7.4%为非二元性别/其他;10.2%为黑人/非裔美国人,62.6%为白人,18.5%为多种族裔,8.7%为其他种族;16.2%为西班牙裔;42.5%为性少数群体;76.2%在醒来后 30 分钟内吸电子烟。7 个月的随访率为 70.8%。干预组的点前戒烟率为 37.8%(95%CI,34.4%-41.3%),对照组为 28.0%(95%CI,24.9%-31.3%)(相对风险,1.35[95%CI,1.17-1.57];P < .001)。没有基线变量调节治疗效果关系。没有证据表明戒烟的青少年转向可燃烟草产品。
通过社交媒体渠道招募的青少年中,个性化、互动的短信干预增加了自我报告的电子烟戒除率。
ClinicalTrials.gov 标识符:NCT04919590。